| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 19, 2026 | Option exercise(M) | 50K | $4.14 | $207K | 895K |
| Aug 19, 2026 | Sell(S) | 43K | $15.36 | $663K | 852K |
| Aug 19, 2026 | Sell(S) | 26K | $16.42 | $426K | 826K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 19, 2026 | Option exercise(M) | 50K | — | $0 | 218K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-361096) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for 4D Molecular Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.